CARDIOVASCULAR & PULMONARY BIOLOGY

Computer rendering of heart with heartline

Dabertrand, Fabrice
Associate Professor
PhD, University of Bordeaux Segalen, France
The control of cerebral blood flow by ion channels and calcium signaling in the pericytes, endothelial cells, and smooth muscle cells that constitute the brain microcirculation. We use this information to combat brain diseases with a vascular component.

Gerber, Anthony N.
Professor
MD/PhD, 1998, Univ. of Washington
Targeting the glucocorticoid receptor for the treatment of inflammatory disorders of the lung such as asthma.

Lahm, Timothy
Professor of Medicine
MD, 2000, University of Heidelberg
Pulmonary hypertension, right heart failure, sex differences in cardiopulmonary disease, estrogen signaling in the lung and right ventricle, angiogenesis and endothelial cell function in pulmonary vascular disease and right heart failure, hypoxia-induced cardiac and lung vascular remodeling, neurohormonal signaling in right heart failure, androgen signaling in asthma

McKinsey, Timothy A.
Associate Professor
PhD, 1998, Vanderbilt Univ.
Epigenetic regulation of heart failure; signaling and transcriptional mechanisms of muscle disease.

Port, J. David
Professor
PhD, 1989, Univ. of Utah
G-protein linked receptors and their regulation; regulation of mRNA stability.

Proenza, Catherine
Assistant Professor
PhD, 1999, Colorado State Univ.
We are interested in the cellular and molecular machinery responsible for cardiac pacemaking and its regulation by the autonomic nervous system.

Song, Kunhua
Associate Professor
Ph.D., 2007, Univ. of Texas
Southwestern Medical Center
Translational research of heart disease and heart regeneration.

Sucharov, Carmen
Assistant Professor
PhD, 1997, Univ. of Pennsylvania/ Univ. Federal do Rio de Janerio
Signal transduction and gene expression in adult and pediatric human heart failure.

Weiser-Evans, Mary C.M.
Professor
PhD, 1992, Colorado State Univ.
Defining the molecular signaling mechanisms regulating vascular smooth muscle cell function in the setting of vascular fibroproliferative diseases, including restenosis and pulmonary hypertension.